醒脑静治疗急性脑梗死伴意识障碍患者的研究进展
摘要
关键词
全文:
PDF参考
张水昌.醒脑静注射液联合穿刺引流术治疗基底节区中度脑出血的临床疗效[J].中西医结合心脑血管病杂志,2019,17(4):639-640.
吴婉玉,廖峻,黄劼,等.醒脑注射液在脑梗死患者中的应用及安全性研究[J].河北医学,2017,23(8):1304-1307.
Zhang YM, Qu XY, Zhai JH, et al. Xingnaojing Injection Protects against Cerebral Ischemia Reperfusion Injury via PI3K/Akt-Mediated eNOS Phosphorylation[J]. Evidence-based complementary and alternative medicine,2018:2361046.
Zhang YM, Qu XY, Tao LN, et al. XingNaoJing injection ameliorates cerebral ischaemia/reperfusion injury via SIRT1-mediated inflammatory response inhibition[J].Pharm Biol, 2020,58(1):16-24.
吴京霓,刘瑞敏,许丹妮,等.基于GC-MS技术及网络药理学探讨醒脑静注射液入脑成分抗脑缺血损伤的作用机制[J].中草药,2021,52(3):808-820.
赵婷婷,焦黛妍,吴兆华.醒脑静注射液治疗急性脑卒中伴意识障碍的临床研究[J].中西医结合心脑血管病杂志,2022,20(17):3224-3227.
胡瑾瑜.醒脑静注射液治疗急性脑卒中伴意识障碍患者效果及对脑功能影响[J].上海医药,2020,41(4):25-26+48.
Liu H, An N, Wang L, et al. Protective effect of Xingnaojing injection on ferroptosis after cerebral ischemia injury in MCAO rats and SH-SY5Y cells[J].Ethnopharmacol,2023,301:115836.
Wang L, Fan X, Chen Y, et al. Efficacy and Safety of Xingnaojing Injection for Emergency Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis[J].Front Pharmacol, 2022,13:839305.
Chen Y, Tian Z, Wang S, et al. Trial of a prehospital intervention with traditional Chinese medicine for acute stroke (TRACE): Protocol for a mixed-methods research study[J].Front Pharmacol, 2022(13):879282.
曹竟,耿洪娇,黎元元,等.真实世界醒脑静注射液治疗脑梗死人群疑似过敏反应影响因素研究[J].中国中医基础医学杂志,2023,29(10):1701-1704.
陈玉清,张艳娟.醒脑静注射液的作用机制、临床应用和不良反应的研究[J].中国药物滥用防治杂志,2023,29(10):1764-1767.
DOI: http://dx.doi.org/10.12345/yzlcyxzz.v7i2.16310
Refbacks
- 当前没有refback。
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。